Abstract:Purpose: To review how REM sleep behavior disorder (RBD) is a complex condition with heterogeneous underlying disorders; and to review clinical management issues and prognostic implications. Methods: PubMed literature search and contents from the first textbook of RBD (2018). Results: RBD, with its core objective diagnostic feature of REM-without-atonia (RWA) documented by video-polysomnography, can emerge during the entire lifespan, and can initially present as an idiopathic (isolated) condition (iRBD), or can be associated with a broad spectrum of disorders including narcolepsy, alpha-synuclein neurodegenerative disorders (esp. Parkinson's disease [PD] and dementia with Lewy bodies [DLB]), paraneoplastic neurological syndromes and autoimmune disorders, CNS lesions (e.g., tumors, stroke), other neurological disorders, psychiatric disorders (PTSD, mood disorders), can be triggered by antidepressant/other medications, and can emerge acutely with drug withdrawal states, toxic-metabolic states, etc. Important clinical issues include the evolution of iRBD to PD/DLB in most middle-aged and older patients over a period of years to several decades, with compelling prognostic implications, along with the hope of enrolling these patients in future clinical trials to test promising disease-modifying therapies. Also, the strong link of RBD with narcolepsy needs further investigation. Parasomnia overlap disorder involves RBD and NREM parasomnias that can be idiopathic or linked with a broad range of clinical disorders. RBD usually responds to therapy consisting mainly of melatonin and/or clonazepam at bedtime. The complex associations of RBD with OSA are being increasingly investigated. RBD mimics with dream-enactment need to be recognized for diagnostic and management purposes, including severe OSA, NREM parasomnias, PLMD, nocturnal seizures, and other conditions. Conclusions: The clinical and research RBD fields span across the disciplines of neurology, pulmonary, psychiatry, psychology, and pediatric sleep medicine, along with physical medicine and rehabilitation medicine, other allied disciplines, and the basic and clinical neurosciences.

REM Behavior Disorder: Implications for PD Therapeutics

REM Sleep Behaviour Disorder: Prodromal and Mechanistic Insights for Parkinson's Disease

Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease

Sleep Disturbances in Parkinson's Disease With Emphasis on Rapid Eye Movement Sleep Behavior Disorder

Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease

RBD and Neurodegenerative Diseases.

Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases

History of symptoms consistent with REM sleep behavior disorder in a population with Parkinson's Disease

REM sleep behavior disorder: update on diagnosis and management

Rapid eye movement sleep behaviour disorder in children and adolescents

Morbidities in rapid eye movement sleep behavior disorder

Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: An Update

Two polysomnographic features of REM sleep behavior disorder: Clinical variations insight for Parkinson's disease.

REM sleep behavior disorder and neuropathology in Parkinson's disease

Secondary RBD: Not just neurodegeneration

Electroencephalographic Finding in Idiopathic REM Sleep Behavior Disorder

REM sleep behavior disorder as a complex condition with heterogeneous underlying disorders: clinical management and prognostic implications [Commentary]

Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism

A high-density electroencephalography study reveals abnormal sleep homeostasis in patients with rapid eye movement sleep behavior disorder

Review of rapid eye movement behavior sleep disorders

Is REM sleep behavior disorder a friend or foe of obstructive sleep apnea? Clinical and etiological implications for neurodegeneration